Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) study

American Heart Journal

Volumn 157, Issue 4, 2009, Pages 680-687

  Beygui, Farzin ^a   Montalescot, Gilles ^a   Vicaut, Eric ^b   Rouanet, Stephanie ^c   Van Belle, Eric ^d   Baulac, Cathrine ^e   Degrandsart, Alexia ^e   Dallongeville, Jean ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hopital F VIDAL   (France)

^c THERAPHARM Recherches   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e PFIZER INC   (United States)

^f INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ALDOSTERONE BLOOD LEVEL; ARTICLE; DEATH; FEMALE; FOLLOW UP; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RESUSCITATION; ST SEGMENT ELEVATION; STROKE;

EID: 62949146402     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.12.013     Document Type: Article

References (26)

1. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
2. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
3. Sadeghi H.M., Stone G.W., Grines C.L., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
4. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
5. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
6. Mega J.L., Morrow D.A., De Lemos J.A., et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 44 (2004) 335-339
7. Richards A.M., Nicholls M.G., Espiner E.A., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
8. Yip H.K., Hang C.L., Fang C.Y., et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 127 (2005) 803-808
9. Nikfardjam M., Mullner M., Schreiber W., et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 247 (2000) 341-345
10. Suleiman M., Aronson D., Reisner S.A., et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 115 (2003) 695-701
11. Beygui F., Collet J.P., Benoliel J.J., et al. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation 114 (2006) 2604-2610
12. Cohn J.N., and Colucci W. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. Am J Cardiol 97 (2006) 4F-12F
13. Connell J.M., and Davies E. The new biology of aldosterone. J Endocrinol 186 (2005) 1-20
14. Weber K.T., Gerling I.C., Kiani M.F., et al. Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets. Curr Drug Targets 4 (2003) 505-516
15. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
16. Montalescot G., Dallongeville J., Van Belle E., et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 28 (2007) 1409-1417
17. Guerrero V., and Johnson R. Use of the Box-Cox transformation with binary response models. Biometrika 69 (1982) 309-314
18. Steyerberg E.W., Harrell Jr. F.E., Borsboom G.J., et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54 (2001) 774-781
19. Weber K.T., Sun Y., Wodi L.A., et al. Toward a broader understanding of aldosterone in congestive heart failure. J Renin Angiotensin Aldosterone Syst 4 (2003) 155-163
20. Rouleau J.L., Packer M., Moye L., et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 24 (1994) 583-591
21. Guder G., Bauersachs J., Frantz S., et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 115 (2007) 1754-1761
22. Rocha R., Stier Jr. C.T., Kifor I., et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141 (2000) 3871-3878
23. Rocha R., Martin-Berger C.L., Yang P., et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143 (2002) 4828-4836
24. Hayashi M., Tsutamoto T., Wada A., et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 107 (2003) 2559-2565
25. Palmer B.R., Pilbrow A.P., Frampton C.M., et al. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. Eur Heart J 29 (2008) 2489-2496
26. Steg P.G., Ravaud P., Tedgui A., et al. Predischarge C-reactive protein and 1-year outcome after acute coronary syndromes. Am J Med 119 (2006) 684-692